文献速递骨质疏松与代谢性骨病

骨质疏松症与心血管疾病之间的联系:共享机制、危险因素及治疗方法的综述

The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches.
PubMed 文献 · Osteoporos Int · 2025-06-02

本综述探讨骨质疏松症(OP)与心血管疾病(CVD)之间共享的炎症、氧化应激及OPG系统等通路,流行病学研究显示低骨密度与心血管死亡和发病风险增加相关,双膦酸盐、地舒单抗和他汀类药物可能对两者均有益,但确切分子机制尚不明确,需进一步研究。

要点

  • 低骨密度与心血管死亡和发病风险增加相关。
  • 炎症、氧化应激及OPG系统参与骨丢失和血管钙化。
  • 双膦酸盐、地舒单抗和他汀类药物可能同时改善骨骼和心血管结局。

核心结论

  • 本综述总结了OP与CVD共享的病理生理、危险因素和治疗方法,强调需要整合管理策略。

研究设计与样本

  • 本文为综述,探讨OP与CVD之间共享的通路和危险因素。

主要发现

  • 流行病学研究显示低骨密度与心血管死亡和发病风险增加相关。
  • 血管平滑肌细胞的成骨分化和骨相关蛋白如骨桥蛋白和OPG进一步凸显骨代谢与心血管健康的重叠。
  • 衰老、雌激素缺乏、维生素D不足以及吸烟和缺乏体力活动等生活方式因素将OP与CVD联系起来。
  • 双膦酸盐、地舒单抗和他汀类药物已显示出应对这两种疾病的潜力。
  • 这些双重效应的确切分子机制仍不清楚,需要进一步研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这些双重效应的确切分子机制仍不清楚,需要进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteoporosis (OP) and cardiovascular diseases (CVDs) are prevalent age-related conditions that share common risk factors and underlying mechanisms, suggesting a bidirectional relationship. METHODS: This review explores the intricate link between OP and CVD, focusing on shared pathways such as inflammation, oxidative stress, and the receptor activator of the nuclear factor-κB ligand-osteoprotegerin (OPG) system, which contribute to both bone loss and vascular calcification. Epidemiological studies reveal that low bone mineral density has been linked to an increased risk of cardiovascular mortality and morbidity, highlighting the interconnected nature of these conditions. RESULTS: Key biological processes, including the osteogenic differentiation of vascular smooth muscle cells (VSMCs) and the role of bone-related proteins like osteopontin (OPN) and OPG, further underscore the overlap between bone metabolism and cardiovascular health. Common risk factors, such as aging, estrogen deficiency, vitamin D insufficiency, and lifestyle factors like smoking and physical inactivity, further link OP and CVD. Therapeutic interventions, including bisphosphonates, denosumab, and statins, have shown potential in addressing both conditions, suggesting that treatments targeting bone health may also benefit cardiovascular outcomes. However, the precise molecular mechanisms underlying these dual effects remain unclear, necessitating further research. CONCLUSION: This review synthesizes current knowledge on the shared pathophysiology, risk factors, and therapeutic approaches for OP and CVD, emphasizing the need for integrated management strategies. By understanding the interplay between bone and cardiovascular health, healthcare providers can develop more effective, holistic approaches to prevent and treat these interconnected conditions, ultimately improving patient outcomes.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Sharafi MH, Nazari A, Cheraghi M, et al. The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches. Osteoporos Int. 2025. PMID: 40455217. doi:10.1007/s00198-025-07553-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。